206 related articles for article (PubMed ID: 2932382)
21. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
Joiner K; Sher A; Gaither T; Hammer C
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
23. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
Wahn V; Müller W; Rieger C; Rother U
Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
[TBL] [Abstract][Full Text] [Related]
24. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
[TBL] [Abstract][Full Text] [Related]
25. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
26. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid.
Schenkein HA; Genco RJ
J Periodontol; 1977 Dec; 48(12):778-84. PubMed ID: 338883
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the alternative pathway of human complement by C1q.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
Leijh PC; van den Barselaar MT; Daha MR; van Furth R
J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
[TBL] [Abstract][Full Text] [Related]
30. Complement in tears from normal humans.
Yamamoto GK; Allansmith MR
Am J Ophthalmol; 1979 Oct; 88(4):758-63. PubMed ID: 116549
[TBL] [Abstract][Full Text] [Related]
31. Level of complement activity and components C1, C4, C2, and C3 in complement response to bacterial challenge in malnourished rats.
Sakamoto M; Ishii S; Nishioka K; Shimada K
Infect Immun; 1981 May; 32(2):553-6. PubMed ID: 7251136
[TBL] [Abstract][Full Text] [Related]
32. Formation and function of the classical and alternative pathways of complement.
Ogle JD; Ogle CK
Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
[No Abstract] [Full Text] [Related]
33. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
Medof ME; Prince GM; Mold C
Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5047-51. PubMed ID: 6214790
[TBL] [Abstract][Full Text] [Related]
34. Association of alternative complement pathway components with human blood platelets: secretion and localization of factor D and beta 1H Globulin.
Kenney DM; Davis AE
Clin Immunol Immunopathol; 1981 Dec; 21(3):351-63. PubMed ID: 6459901
[No Abstract] [Full Text] [Related]
35. [Paroxysmal nocturnal hemoglobinuria. Increase in proteins of the alternative complement pathway].
de Gramont A; Kazatchkine M; Maillet F; Blanche M; Debray J
Presse Med; 1983 Mar; 12(12):747-50. PubMed ID: 6220312
[TBL] [Abstract][Full Text] [Related]
36. Complement activation in patients with amebic liver abscess.
Muñoz LE; Salazar OG
J Hepatol; 1987 Aug; 5(1):30-6. PubMed ID: 2888804
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
[TBL] [Abstract][Full Text] [Related]
38. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models.
Subías M; Tortajada A; Gastoldi S; Galbusera M; López-Perrote A; Lopez Lde J; González-Fernández FA; Villegas-Martínez A; Dominguez M; Llorca O; Noris M; Morgan BP; Rodríguez de Córdoba S
J Immunol; 2014 Dec; 193(11):5567-75. PubMed ID: 25355917
[TBL] [Abstract][Full Text] [Related]
39. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
Brade V; Beuscher HU
Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
[TBL] [Abstract][Full Text] [Related]
40. Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.
Meri S; Koistinen V; Miettinen A; Törnroth T; Seppälä IJ
J Exp Med; 1992 Apr; 175(4):939-50. PubMed ID: 1532415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
